KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$493000.0.

  • Bionano Genomics' Net Cash Flow rose 9610.68% to -$493000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year increase of 7623.07%. This contributed to the annual value of -$8.8 million for FY2024, which is 16854.28% down from last year.
  • Latest data reveals that Bionano Genomics reported Net Cash Flow of -$493000.0 as of Q3 2025, which was up 9610.68% from -$52000.0 recorded in Q2 2025.
  • Bionano Genomics' Net Cash Flow's 5-year high stood at $323.6 million during Q1 2021, with a 5-year trough of -$191.8 million in Q3 2021.
  • In the last 5 years, Bionano Genomics' Net Cash Flow had a median value of -$523000.0 in 2022 and averaged -$1.9 million.
  • Over the last 5 years, Bionano Genomics' Net Cash Flow had its largest YoY gain of 363014.07% in 2021, and its largest YoY loss of 1156551.11% in 2021.
  • Bionano Genomics' Net Cash Flow (Quarter) stood at -$116.2 million in 2021, then soared by 80.41% to -$22.8 million in 2022, then rose by 26.77% to -$16.7 million in 2023, then skyrocketed by 102.3% to $383000.0 in 2024, then plummeted by 228.72% to -$493000.0 in 2025.
  • Its Net Cash Flow stands at -$493000.0 for Q3 2025, versus -$52000.0 for Q2 2025 and -$6.0 million for Q1 2025.